Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 9 studies | 28% ± 10% | |
| pericyte | 9 studies | 30% ± 7% | |
| myofibroblast cell | 6 studies | 48% ± 19% | |
| capillary endothelial cell | 6 studies | 44% ± 16% | |
| endothelial cell | 5 studies | 33% ± 15% | |
| smooth muscle cell | 5 studies | 54% ± 22% | |
| connective tissue cell | 5 studies | 38% ± 11% | |
| endothelial cell of artery | 4 studies | 29% ± 3% | |
| mesothelial cell | 3 studies | 26% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 4 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 7558.69 | 964 / 966 | 98% | 16.29 | 515 / 527 |
| prostate | 99% | 4905.85 | 243 / 245 | 98% | 19.32 | 490 / 502 |
| stomach | 98% | 4088.79 | 353 / 359 | 98% | 22.84 | 279 / 286 |
| lung | 100% | 6239.52 | 577 / 578 | 93% | 10.52 | 1069 / 1155 |
| esophagus | 92% | 5376.52 | 1324 / 1445 | 97% | 13.20 | 177 / 183 |
| bladder | 100% | 9125.19 | 21 / 21 | 88% | 12.06 | 445 / 504 |
| thymus | 76% | 971.98 | 498 / 653 | 52% | 2.45 | 312 / 605 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.59 | 1 / 1 |
| uterus | 42% | 614.12 | 72 / 170 | 55% | 6.03 | 252 / 459 |
| pancreas | 1% | 4.39 | 2 / 328 | 96% | 13.50 | 171 / 178 |
| brain | 19% | 169.30 | 510 / 2642 | 75% | 4.31 | 527 / 705 |
| kidney | 13% | 124.49 | 12 / 89 | 60% | 5.27 | 541 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 71% | 3.52 | 32 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 1.92 | 15 / 29 |
| skin | 20% | 312.48 | 361 / 1809 | 21% | 1.50 | 97 / 472 |
| liver | 9% | 75.00 | 20 / 226 | 28% | 1.32 | 112 / 406 |
| adrenal gland | 0% | 0 | 0 / 258 | 35% | 1.78 | 81 / 230 |
| adipose | 23% | 214.18 | 272 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 1% | 4.41 | 1 / 180 | 14% | 0.94 | 60 / 430 |
| breast | 6% | 56.58 | 28 / 459 | 6% | 0.20 | 66 / 1118 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.08 | 2 / 80 |
| blood vessel | 2% | 17.18 | 31 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 3.09 | 3 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0043305 | Biological process | negative regulation of mast cell degranulation |
| GO_0045198 | Biological process | establishment of epithelial cell apical/basal polarity |
| GO_0048286 | Biological process | lung alveolus development |
| GO_0007224 | Biological process | smoothened signaling pathway |
| GO_0060841 | Biological process | venous blood vessel development |
| GO_0030324 | Biological process | lung development |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0031016 | Biological process | pancreas development |
| GO_0060438 | Biological process | trachea development |
| GO_0007507 | Biological process | heart development |
| GO_0007368 | Biological process | determination of left/right symmetry |
| GO_0030323 | Biological process | respiratory tube development |
| GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0007494 | Biological process | midgut development |
| GO_0060441 | Biological process | epithelial tube branching involved in lung morphogenesis |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0001570 | Biological process | vasculogenesis |
| GO_0003214 | Biological process | cardiac left ventricle morphogenesis |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0061030 | Biological process | epithelial cell differentiation involved in mammary gland alveolus development |
| GO_0060426 | Biological process | lung vasculature development |
| GO_0060463 | Biological process | lung lobe morphogenesis |
| GO_0048613 | Biological process | embryonic ectodermal digestive tract morphogenesis |
| GO_0002053 | Biological process | positive regulation of mesenchymal cell proliferation |
| GO_0071345 | Biological process | cellular response to cytokine stimulus |
| GO_0050728 | Biological process | negative regulation of inflammatory response |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0001763 | Biological process | morphogenesis of a branching structure |
| GO_0048557 | Biological process | embryonic digestive tract morphogenesis |
| GO_0003197 | Biological process | endocardial cushion development |
| GO_0051145 | Biological process | smooth muscle cell differentiation |
| GO_0001756 | Biological process | somitogenesis |
| GO_0001568 | Biological process | blood vessel development |
| GO_0072189 | Biological process | ureter development |
| GO_0048565 | Biological process | digestive tract development |
| GO_0097070 | Biological process | ductus arteriosus closure |
| GO_0014822 | Biological process | detection of wounding |
| GO_0060461 | Biological process | right lung morphogenesis |
| GO_0048371 | Biological process | lateral mesodermal cell differentiation |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0090131 | Biological process | mesenchyme migration |
| GO_0071407 | Biological process | cellular response to organic cyclic compound |
| GO_0048617 | Biological process | embryonic foregut morphogenesis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| Gene name | FOXF1 |
| Protein name | Forkhead box protein F1 (Forkhead-related activator 1) (FREAC-1) (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1) Forkhead-related activator 1 Forkhead box protein F1 |
| Synonyms | FREAC1 FKHL5 |
| Description | FUNCTION: Probable transcription activator for a number of lung-specific genes. |
| Accessions | Q12946 ENST00000262426.6 Q6JSE1 A0A161DGH1 |
